Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
LGALS14	CLC2, PPL13	ENSG00000006659	Galectin 14	Q8TCE9	19	39704306-39709444	Predicted intracellular proteins	Apoptosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	34	placenta: 110.8	Cell type enriched	Detected in some	72	Syncytiotrophoblasts: 74.1	Cancer enriched	Detected in single	16	liver cancer: 5.3	Not detected	Not detected			Cell type enhanced	Detected in single		naive CD4 T-cell: 3.2	Lineage enriched	Detected in single	5	T-cells: 3.2	Group enriched	Detected in some	5	EFO-21: 5.5;U-266/70: 12.8									HPA065180			Supported	Nucleoplasm						Nucleoplasm		HPA065180: 										unprognostic (1.95e-1)								0	0.2	0.1	0.1	0.1	0.2	1.1	0.1	0.3	1.5	0.1	0	0	0.2	0.1	0.1	0	0.1	0	0	0.1	0.3	0	0	0.2	0.1	0.4	0	0	0.2	0	0.2	110.8	0	0	0	0	0.1	0	0.3	0.6	0.2	0	0.3	0.3	0.1	1.4	0	0.1	0	0	0.2	0	0	0.1	0.3	0.6	0	0	3.2	0.6	0.3	0	0.4	0.7	0	0	1.7	0	0	0.1	0	0.3	0.5	0	5.5	0.1	0.1	0.8	0.1	0	0.3	1.9	0.2	0.1	1	0.4	0	0.2	1.2	0	0.3	0.3	0.4	0.7	0	0.5	0.1	1.4	0	0.5	0.2	0.3	0.2	0	0.4	0	0	0.1	0	0.2	0.4	0.3	0.1	0.4	0.2	0.8	0.1	0.2	0	0.6	0.8	1	0.3	12.8	0.7	0.1	0.4	0.3	0.3	0.6	0	0.2	0.1	0	0.1	0	0.9	0	0	0.1	3.2	0.2	0.6	0	0	0.3	0	0.6	0.1	0.1	0.1	0.3	0.1	0.3	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0.6	0	0	0	0	0.9	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	74.1	0	0	0	Syncytiotrophoblasts
FAR2	FLJ10462, MLSTD1, SDR10E2	ENSG00000064763	Fatty acyl-CoA reductase 2	Q96K12	12	29149103-29340980	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism	Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 162.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		eosinophil: 23.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015884	Approved		Approved	Nucleoli,Golgi apparatus						Golgi apparatus	Nucleoli	HPA015884: AB_1853998	unprognostic (6.32e-2)	unprognostic (2.40e-2)	unprognostic (1.50e-3)	unprognostic (3.33e-3)	unprognostic (2.41e-1)	unprognostic (4.13e-3)	unprognostic (4.30e-2)	unprognostic (1.18e-1)	unprognostic (3.11e-2)	unprognostic (6.37e-2)	unprognostic (5.70e-3)	unprognostic (1.92e-1)	prognostic unfavorable (4.93e-4)	unprognostic (2.10e-1)	unprognostic (2.23e-1)	unprognostic (1.33e-1)	unprognostic (5.22e-3)	9.4	7.2	9.8	6.9	17.4	12	7.6	5.1	18.2	4.6	25.7	3.2	6.1	13.3	6.2	29.4	6	3.7	4.2	5.4	12.8	10.9	4	3.1	8.6	6.7	9.4	10.4	2.1	2.6	1	2.9	19.2	6.6	2.8	22.3	4.1	4.8	1.7	4.5	8.7	14	6	5.1	12.3	3.7	8.4	5.9	7.2	3.5	4.5	2.3	6.6	4.3	0.9	4	23.7	11.5	1.8	7.6	4.4	0.9	1.8	1.8	0.4	2.6	10.1	0.8	7.6	9	2.1	2	3	10.3	1.3	2	1	1.5	0.5	4.7	0	0.5	0.6	11.8	26.3	4.2	0.9	5.4	10.5	8.8	2.8	0	3.2	4.1	5.4	30.8	1	2.3	1	0.3	0.3	6.7	26.4	7.1	0.5	20.1	5.6	2.9	1.1	9.5	2.6	3.1	2.8	1.7	32.5	12.9	3.8	1.5	9.9	25	5.7	1.7	2	3.3	1.6	1.7	0.6	9.1	13.8	4.9	1.3	11.5	23.7	2.7	6.9	1.8	0.9	4.5	3.2	4	0.7	1.5	1.7	20.7	1.8	3.7	1.5	7.6	4.4	9.8	17.4	5.1	18.2	12.8	10.9	9.4	10.4	6.6	5.9	0	3.5	0	0.1	1.1	1.9	8.7	0	4	2.3	0	0	14	0	0	16.3	11.1	22.3	0	0.2	16.9	4.3	0.4	10.4	0	16.4	4.8	6.9	3.7	19.8	4.2	1.1	7.2	15.1	1	19.9	0.4	1.9	31.9	0.4	0.3	1.1	0	3.3	0.2	0.9	0.3	162.1	4.4	19.4	0.1	Syncytiotrophoblasts
BCORL1	CXorf10, FLJ11362	ENSG00000085185	BCL6 corepressor like 1	Q5H9F3	X	129981107-130058083	Cancer-related genes, Predicted intracellular proteins	Transcription, Transcription regulation	Chromatin regulator, Repressor	Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Syncytiotrophoblasts: 78.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		AN3-CA: 20.4;HAP1: 30.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031775, HPA031777, HPA068568	Uncertain		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm	Plasma membrane	HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007	unprognostic (8.07e-2)	unprognostic (2.78e-2)	unprognostic (7.09e-2)	prognostic unfavorable (2.20e-5)	unprognostic (4.58e-1)	unprognostic (1.68e-3)	unprognostic (1.96e-3)	unprognostic (5.56e-3)	unprognostic (2.39e-1)	unprognostic (8.02e-2)	unprognostic (4.46e-2)	unprognostic (2.04e-1)	prognostic unfavorable (5.00e-4)	unprognostic (9.18e-2)	unprognostic (2.60e-2)	unprognostic (3.09e-1)	unprognostic (1.41e-2)	7.5	7.9	7.7	5.2	9.1	9.8	9.1	19.8	10.5	8.7	8.3	10.7	8.1	5.4	9.2	5.4	5.8	9.3	4.2	6.9	8.4	4.5	7.5	4.7	6.7	5.3	7.6	5.9	11.4	8.9	13.4	15	28.9	7.5	8.1	4.5	6	6.5	8.4	6	6.5	6	8.8	5.3	7.7	6.6	26.1	8.1	6.8	10.3	2.2	5.1	6.7	8.5	1.2	1.6	3.5	1.3	0.8	1.3	0.7	2.2	5.5	12.9	20.4	7.6	5.5	3.6	3	3.5	3.9	4.5	6.6	1.4	1	6.7	6	3.7	1.3	30.8	1.2	3.7	2.2	4.5	10.6	2.7	2.2	3.8	2.6	3.1	3.4	2.5	7.7	0.4	5.8	4.7	3.5	5.1	10.8	2.5	1.3	3.9	8	3.5	1.8	3.9	8.3	5.2	1.4	2.2	0.3	2.1	7.3	1.6	0.4	2	7.2	4.5	4	3.9	3.2	4.1	3.8	2.9	3.5	6.3	1.6	2.1	5.4	1.5	0.1	1.3	2.8	1.3	0.2	1	1.2	0.9	0.8	1.6	1	0.6	0.7	3.5	0.8	0.5	0.7	0.2	0.7	7.7	9.1	19.8	10.5	8.4	4.5	7.6	5.9	7.5	8.1	0	3.2	0	2.3	10.5	1.8	6.4	5.1	2.7	1.2	7	0	10.7	0	3.2	0.4	7.1	2.7	0	0.9	4.2	5.8	2.9	6.9	3	2.8	7.9	11.5	3.1	2.6	1	4.4	1.8	6.8	1	1.7	3.1	2.3	0	3.5	2.2	1	6.5	4.5	3.5	5.3	10	78.1	1.5	2.8	2.5	Syncytiotrophoblasts
CGB2		ENSG00000104818	Chorionic gonadotropin beta subunit 2		19	49031912-49033238	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in some		brain: 2.1;testis: 4.1	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 33.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted in other tissues					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277										unprognostic (3.05e-2)								0	0	0.2	0	2.1	0	0	0	0.6	0	0			0	0	0.7	0.3	0	0	1.1	1	0.9	0.2	0	0	0.4	0.1		0	0	0	1.1	1.4		0.4	0		0	0	0.5	0.6	0	0	0	0.1	0.3	4.1			0.1		0.1	0	0.2	0	0	0	0	0	0	0	1.3	0.5	0	0.2	0	0	1.3	0	0	0	0	0	0.3	0	0	0	0.1	0.1	0.2	0	0	3.4	0	0.4	0	0	0.1	0	25.4	0	0	0	0	0.4	0	0	0.3	0	0	0	0	0	0.1	0.8	0	0	0	0	0	0.1	0	0	0.2	0	0	0.2	0	0	0	0.4	0.7	0	3	10.2	12.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.4	0	0	6.5	0	0.5	1.1	0	33.4	0	0	0	Syncytiotrophoblasts
CGB3	CGB	ENSG00000104827	Chorionic gonadotropin beta subunit 3	P0DN86	19	49022869-49024333	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		pituitary gland: 6.7;placenta: 15.0	Cell type enriched	Detected in some	38	Syncytiotrophoblasts: 724.1	Cancer enhanced	Detected in some		pancreatic cancer: 2.9;testis cancer: 4.2					Cell type enhanced	Detected in single		T-reg: 1.0	Lineage enriched	Detected in single	6	T-cells: 1.0	Cell line enriched	Detected in some	20	BEWO: 39.7									CAB000042, CAB010884, HPA038925, HPA038934	Enhanced		Approved	Cytosol	Secreted to blood					Cytosol		CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277									unprognostic (1.39e-1)		unprognostic (7.88e-2)				unprognostic (6.92e-2)		unprognostic (1.04e-2)	0	0	0	0	0	0	0	0	0	0	0			0.4	0	0	0	0	0	0	0	0	0	0	0	0	0		0	3.2	0	6.7	15		0	0		0.1	0	0	0	0.1	0	0	0	0.1	1			0		0	0	0	0.1	0	0	0.1	0	1	0	0.2	0	0	0.1	0	0	39.7	0	0	0	0	0	0.7	0.1	0	0.1	0	0	0	0	0	0.8	0.3	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0.1	0.3	0.3	0	0	0	0.1	0.1	0	0	0.1	0.1	0.1	0	0.1	0.1	0	0.2	0	0	1.3	0.5	0	0	0.1	0.2	0	1.9	0.7	0.5	0.1	0	0.1	0	0	0.1	0	0.4	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	1	0											0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	19.2	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	6.1	0	0	0	0	0	0	0	0	0	724.1	0	0	0	Syncytiotrophoblasts
LGALS13	PLAC8, PP13	ENSG00000105198	Galectin 13	Q9UHV8	19	39602501-39607476	Predicted intracellular proteins	Apoptosis	Hemagglutinin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	placenta: 58.9	Cell type enriched	Detected in some	19	Syncytiotrophoblasts: 267.5	Cancer enhanced	Detected in single		thyroid cancer: 0.5	Group enriched	Detected in some	7	cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	73	SuSa: 7.3									HPA046803			Supported	Nucleoplasm						Nucleoplasm		HPA046803: AB_10965990																		0	0	0.1	0	0.1	0	0	1.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	2	0	0	0	0	0	58.9	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0	0.2	1.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	1.5	0.2	0	1.2	2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	4.3	0	0	0	0	1.5	0	0	0	0	3.5	0	0	0	0	14.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	267.5	0	0	0	Syncytiotrophoblasts
HSD17B1	EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1	ENSG00000108786	Hydroxysteroid 17-beta dehydrogenase 1	P14061	17	42549214-42555213	Enzymes, Predicted intracellular proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	25	placenta: 217.6	Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 1251.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enriched	Detected in many	8	BEWO: 89.7	Low region specificity	Detected in single							HPA021032, HPA065296	Enhanced		Supported	Cytosol						Cytosol		HPA021032: AB_1844345, HPA065296: AB_2685457	unprognostic (1.13e-1)	unprognostic (1.40e-2)	unprognostic (1.68e-2)	unprognostic (9.25e-2)	unprognostic (1.73e-1)	unprognostic (3.88e-2)	unprognostic (1.14e-1)	unprognostic (1.10e-1)	unprognostic (9.35e-2)	unprognostic (6.04e-2)	unprognostic (2.88e-5)	unprognostic (2.17e-1)	unprognostic (1.30e-1)	unprognostic (2.60e-2)	unprognostic (5.09e-1)	unprognostic (4.98e-1)	unprognostic (1.32e-2)	2.8	1.5	2	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.8	0.9	4.6	0.6	0.1	89.7	1.2	0	0	0	1	0.9	0	1.2	0	1	2.6	0.1	0.7	0	2.4	2.8	1.2	1.1	1.5	0.2	1	1.4	0.2	2.6	0.1	0.5	1.5	0	1.3	1.7	0.4	0	1.6	1.3	1.1	0.4	0.6	0.8	1.3	1.1	0.8	0.1	1.4	1.3	1.8	0.7	9.1	1.4	1	11	0.8	1.4	1.4	1.8	1	0.8	2.6	1.5	0.6	0.6	0.9	1.1	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3	0	2.1	0.5	6.3	2.7	8.7	2.4	2.5	4	2.3	5.2	11.8	250.4	19.9	1.5	1	4.1	3.2	0	4.9	23.6	3.4	13	2.3	5.6	26.4	9.5	4.1	4.9	0.8	1.7	1.7	0.5	1.7	1	2.4	9	2	2.5	3.2	10.5	8.2	0	2.8	0.7	2.6	6.5	1251	1.3	1.9	8.4	Syncytiotrophoblasts
ST3GAL4	CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ	ENSG00000110080	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	Q11206	11	126355640-126440344	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 74.2	Cell type enriched	Detected in many	9	Syncytiotrophoblasts: 804.9	Cancer enhanced	Detected in all		melanoma: 57.2	Low region specificity	Detected in all			Group enriched	Detected in many	4	basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6	Group enriched	Detected in many	11	dendritic cells: 29.6;granulocytes: 31.3	Cell line enhanced	Detected in many		SK-MEL-30: 45.3;WM-115: 102.8	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA049827	Approved				Intracellular and membrane							HPA049827: AB_2680900	unprognostic (8.89e-2)	unprognostic (1.10e-2)	unprognostic (4.92e-2)	unprognostic (6.93e-2)	unprognostic (8.33e-2)	unprognostic (3.80e-2)	unprognostic (2.71e-3)	unprognostic (1.90e-3)	unprognostic (2.62e-1)	unprognostic (1.80e-2)	unprognostic (1.57e-1)	unprognostic (1.45e-1)	unprognostic (3.16e-3)	unprognostic (2.79e-2)	unprognostic (1.28e-1)	unprognostic (8.36e-3)	unprognostic (8.78e-3)	7.8	38	6.2	6.5	12.2	7.8	12.9	4	13.6	8.3	27	26.4	5.1	2	6	42.1	25.5	6	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9	18.7	9	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8	1.9	5.6	3.8	11	23	17	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.9	4.1	3.2	2.7	9.5	7.9	8	5.7	11.1	5.2	3.6	2.4	8.5	1.4	4.3	9	17.7	7.7	6.7	3.7	4.1	5.3	1.9	12.6	10.2	2.7	6.2	15	25.8	6.3	6	7.8	12.4	9.6	6.9	5.5	7.8	3.8	6.4	20.2	4.7	15.4	2	31.9	26.8	4.9	9.9	0.6	1.2	14.2	6.1	3.9	6.3	38.2	45.3	2.2	13.3	10	2.5	12.5	2.8	8.8	10.7	0.3	0.8	0.7	5.7	23	102.8	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0	0.1	0.8	22.8	1.2	1.2	29.6	0	1.8	6.2	12.2	4	13.6	8.6	6.2	18.7	9	13.8	12.4	8.9	1.1	3.7	5.3	9.4	4.2	26.6	7.6	1.4	4.5	29.6	9.8	90.3	41.4	4.3	1.1	9.8	34.8	0	5.6	59	44	13.8	41.5	8.9	16.2	4.8	5.1	36.8	4.1	3.8	70.5	7.2	74.2	10.8	43.5	5	7.3	93	88.1	3.4	8.3	12.9	23.6	1.4	3.8	5.8	804.9	12.2	8.8	13.1	Syncytiotrophoblasts
INSL4	EPIL	ENSG00000120211	Insulin like 4	Q14641	9	5231419-5235304	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	47	placenta: 88.0	Cell type enriched	Detected in some	11	Syncytiotrophoblasts: 2990.3	Cancer enhanced	Detected in some		lung cancer: 1.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	11	A549: 23.6									HPA065145			Approved	Vesicles	Secreted to blood					Vesicles		HPA065145: 		unprognostic (9.77e-2)						unprognostic (2.02e-1)		unprognostic (4.66e-1)				unprognostic (7.74e-2)				0.1	0.1	0	0	0.1	0.3	0.2	0	0.1	0.1	0.1	0	0	0	0.2	1.8	0.1	0	0	0.2	0	0.1	0.8	0.1	0.2	0	0.1	0	0.1	0.1	0	0	88	0	0.1	0	0.1	0	0	0.3	0.2	0.1	0	0.1	0.2	0.3	0.3	0	0	0.1	0	0	0	0.1	0.2	0	0.1	0.3	0	0.1	0	0	23.6	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	2.1	0.3	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.2	0	0	0	0	0.2	0.1	0	0.1	0	0.4	0	2.1	0	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0.3	0	0.1	0.3	0	0.2	0	0	0	0	0.1	0.1	0.1	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	269	0	0	0.7	0	0	0	0	19.9	0	0	0	0	34.6	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	2990.3	0	0	0	Syncytiotrophoblasts
NFYB	CBF-A, HAP3, NF-YB	ENSG00000120837	Nuclear transcription factor Y subunit beta	P25208	12	104117077-104138289	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		ductus deferens: 107.1	Cell type enriched	Detected in all	4	Syncytiotrophoblasts: 362.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		SK-BR-3: 60.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB004211, HPA065646	Supported		Supported	Nucleoplasm						Nucleoplasm		CAB004211: AB_628018, HPA065646: 	unprognostic (5.82e-2)	unprognostic (2.44e-3)	unprognostic (4.90e-2)	unprognostic (7.10e-3)	unprognostic (2.67e-1)	unprognostic (4.65e-2)	unprognostic (2.10e-2)	unprognostic (2.44e-1)	unprognostic (7.36e-2)	unprognostic (2.63e-1)	unprognostic (9.39e-2)	unprognostic (8.51e-2)	prognostic unfavorable (9.28e-5)	unprognostic (1.62e-3)	unprognostic (4.98e-2)	unprognostic (1.36e-1)	unprognostic (4.81e-3)	16.1	23.4	22.2	13.9	21.3	10.8	17.5	18.5	17.5	16.1	28.2	13.6	107.1	9.9	16.8	25.8	13.7	16	13.7	20	22.6	16.9	15.4	21.8	16	17.4	21.9	12.4	15.9	11.3	17.3	19	16.3	15.6	23.5	14.4	10.1	10.3	53.7	18.5	11.2	10.6	20	24.9	10.1	13.8	13.7	20.4	21.4	19.2	13.5	18.5	20.2	27.9	15.6	7.4	22.8	10.2	15.1	21.1	10.7	13.7	11.9	22.7	13.8	15.3	16.7	21.4	13.8	11.4	15.3	10.5	8.8	6.5	18.5	6.7	12.3	10	9.1	18.2	8.8	16.6	12.6	5.7	11.2	13.3	8.1	16.1	15.9	7.8	24.1	12	6.2	12	27.8	9.9	16.8	10.8	7.5	12.7	15.6	20	16	21.4	10	12.9	18.8	13.1	8.1	10.8	14	13.6	11.2	24.2	60.4	7.8	17.6	22.6	16.4	7.4	9	6.1	8.1	9.9	14.4	12.3	20.6	5.7	9.8	9.2	17.3	7.5	22.8	16.3	9.5	21.1	15.6	15.7	17.1	7.4	11.3	17.5	17.4	10.5	15.1	10.2	6.8	20.5	10.7	22.2	21.3	18.5	17.5	22.6	16.9	21.9	12.4	15.6	20.4	50.6	26.1	11.9	86.4	33.2	21.7	32.7	10.2	25.4	27.3	17.4	3.9	51.6	31.5	20.9	2.8	30.3	11.3	23.3	15.8	71.2	32.7	42.2	20.8	28	20.2	14.3	11.5	52.2	13	4.5	31.7	23	27	18	15.1	27.5	22.7	14.4	28.7	28.6	23.3	19.4	31.9	67.7	31.1	32.4	362.3	27.7	13.4	49.2	Syncytiotrophoblasts
INHA		ENSG00000123999	Inhibin alpha subunit	P05111	2	219569162-219575713	Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6	Cell type enriched	Detected in many	9	Syncytiotrophoblasts: 276.8	Low cancer specificity	Detected in many			Region enriched	Detected in some	5	basal ganglia: 8.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6	Low region specificity	Detected in all			Not detected	Not detected			CAB000047, HPA019141, HPA048834	Enhanced		Approved	Golgi apparatus,Vesicles	Secreted to blood					Vesicles	Golgi apparatus	CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: 	unprognostic (8.90e-3)	unprognostic (2.91e-2)	unprognostic (2.82e-1)	unprognostic (7.55e-2)	unprognostic (1.02e-3)	unprognostic (1.45e-1)	unprognostic (3.57e-1)	unprognostic (9.61e-3)	unprognostic (4.15e-3)	unprognostic (6.71e-2)	unprognostic (3.73e-1)	unprognostic (7.34e-2)	prognostic unfavorable (4.03e-5)	unprognostic (4.85e-2)	unprognostic (7.20e-2)	unprognostic (1.93e-1)	unprognostic (4.43e-2)	0.5	24.2	0.8	0.5	8.4	0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0	0	0	0	0	0	0	0.5	0.4	0.1	2.5	0.8	0.2	4.5	0.5	0.4	0.7	0.2	0.3	4.3	0	0.3	1	0.7	2.6	0.3	0.7	0	0	0.8	5.6	2	3	0.4	0	0	0.9	1.3	0	0.7	2.5	0	0	3.3	0	0.1	3	0	0.2	1.7	0.2	1.1	0.1	0.2	0	0.7	0.3	0.4	1	1.6	12.8	0.4	6.6	0.8	0	0.1	0.5	0.2	0.2	0	0	0	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5	0	0	0	0.1	0	3.4	1.4	0	0	0	7	2	6	0	1.5	0.7	0	0	0	7.9	29.6	0.2	0	0	0	2.3	6.4	0	1.3	0.3	4.1	3.7	0	0	0	0	3.3	3.3	0	1.4	0	0	0	0	1.1	0.4	0	276.8	0	0	0	Syncytiotrophoblasts
PSG8		ENSG00000124467	Pregnancy specific beta-1-glycoprotein 8	Q9UQ74	19	42752686-42855691	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	88	placenta: 142.2	Cell type enriched	Detected in some	12	Syncytiotrophoblasts: 28.7	Cancer enriched	Detected in single	17	thyroid cancer: 0.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;SuSa: 1.7;U-2197: 2.5									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624																unprognostic (1.85e-2)		0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	1	0.2	142.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	1.6	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0.8	0.6	0.4	0	0	1.1	0	0.1	0.1	0.7	0	0.2	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	1.7	0	0	0.5	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.7	2.4	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.7	0	0	0	Syncytiotrophoblasts
GADD45G	CR6, DDIT2, GADD45gamma, GRP17	ENSG00000130222	Growth arrest and DNA damage inducible gamma	O95257	9	89605013-89606555	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Apoptosis, Differentiation	Developmental protein	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in all		placenta: 65.6	Cell type enriched	Detected in many	8	Syncytiotrophoblasts: 1345.9	Cancer enhanced	Detected in all		prostate cancer: 79.8	Low region specificity	Detected in all			Cell type enriched	Detected in some	7	eosinophil: 8.0	Lineage enriched	Detected in single	22	granulocytes: 8.0	Group enriched	Detected in some	4	HDLM-2: 47.8;SCLC-21H: 25.2	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA023606	Approved											HPA023606: AB_1849409	unprognostic (5.84e-2)	unprognostic (1.61e-2)	unprognostic (1.08e-2)	prognostic favorable (7.06e-4)	unprognostic (4.45e-2)	unprognostic (1.85e-1)	unprognostic (1.77e-3)	unprognostic (3.75e-2)	unprognostic (7.65e-3)	unprognostic (4.16e-3)	prognostic favorable (3.80e-5)	unprognostic (1.11e-1)	unprognostic (1.63e-2)	unprognostic (4.95e-1)	unprognostic (3.88e-2)	unprognostic (3.41e-1)	unprognostic (1.22e-1)	7	23.6	4.6	4.4	7.7	8.4	6.7	4.8	5.4	23.3	7.4	2.8	12	4.2	21.3	6.5	6.1	6.4	5.9	53.4	4.1	3.8	6.7	48.4	4.6	1.5	5.3	3.7	14.1	28.7	4.9	25.4	65.6	7.4	12.7	1.6	3	14.7	10.2	58	5.5	6	5.5	6.7	1.3	6.5	13	3	0.8	8.4	26.8	2.6	5.1	6.2	0	0.2	8	0.3	0	0.1	0.1	1.2	0	6.8	0	0	0	9	0.4	0	0	0	1	0.1	0	1.1	0	0.3	1	2.2	0	0	47.8	0.4	0.1	0.1	0	0.3	0	0.1	0.2	0.8	0	0	0	0.1	0	0.1	0	0	1.9	0.1	0.4	6.3	1.1	0.1	0.5	2	0.4	0	0.3	25.2	5.7	0.4	2.6	0	1.3	1	0	0.8	0	0.1	0	0	0	0	0	0	0	0	0	0.3	8	0	0	0	0	0.1	0	0.2	0	0	0	1.2	0	0	0.2	0.1	0.1	4.6	7.7	4.8	5.4	4.1	3.8	5.3	3.7	7.4	3	6	50.9	0.5	17.9	25.3	38.5	139.3	68.8	34.8	33	10.4	5.9	64.8	77.9	10.9	1.3	20.7	22.6	0	37.3	9.4	67.6	115.9	18.5	161.3	53.6	3.2	52.5	8.6	11.6	7.4	78.2	47.7	33.7	19	25.9	28.3	24.6	5.7	42.8	35.3	19.1	129.4	86.5	1.1	1.6	17.1	1345.9	12.1	9.3	8.4	Syncytiotrophoblasts
SLC52A1	FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1	ENSG00000132517	Solute carrier family 52 member 1	Q9NWF4	17	5032600-5052009	Disease related genes, Predicted membrane proteins	Transport	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 25.6;placenta: 34.6	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 685.8	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0																						unprognostic (8.81e-3)	prognostic favorable (9.54e-4)	unprognostic (9.34e-2)	unprognostic (7.30e-4)	unprognostic (6.31e-2)	unprognostic (1.24e-1)	unprognostic (1.05e-1)	unprognostic (3.82e-3)	unprognostic (1.72e-1)	unprognostic (2.36e-1)	unprognostic (1.15e-1)	unprognostic (7.19e-2)	unprognostic (5.17e-5)	unprognostic (1.37e-1)	unprognostic (1.03e-1)	unprognostic (4.07e-2)	unprognostic (6.60e-2)	0.1	0	0.1	0.1	0.2	0.1	0.3	0.3	0.6	1	20	0.2	0.6	24.4	0.5	0.1	1.5	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.2	0.1	1	0.1	34.6	0.3	1.4	0.1	0.1	0.5	0.3	0.1	7.4	25.6	0.1	0.1	0.6	0	0.7	0.1	0.6	0.2	0.4	0.7	2.5	1	1.4	0.6	3.7	0.6	1.4	1.2	0.3	0.2	4.5	0.1	0.2	0.2	0.2	3.8	0	0	0.6	0.6	0.1	0.2	0.3	3.6	0.1	0.7	0.4	0	0.3	0.1	0.1	0.2	0	0.7	0.3	0.1	0.1	9	0.1	0.1	0.2	0.1	0.2	0.2	0.7	0.1	1.2	0	0.3	0.5	0.4	0.4	0.1	0.2	0.1	0	0.3	0.1	1.4	0.1	0.3	0.8	5.1	0.1	0.2	3	1.4	0.6	0.3	1.1	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.5	2.6	0.6	0.9	0.7	0.4	0.6	0.6	0.9	1.2	0.2	1.4	1.1	0.8	3.7	1.4	0.4	0.6	0.5	0.3	0.1	0.2	0.3	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0	0.3	0	1.3	1	0	0.6	0	8.1	0	0	0	134.6	0	0	0.1	0.1	5.7	0	0	10.3	1.1	0.3	0	0	13.6	0	1.2	2.5	0	0	0	0	0	0	1.3	0	0	0.8	0	0	0	0	0	0.9	0.9	1.5	685.8	0	1.1	0.7	Syncytiotrophoblasts
TBX3	TBX3-ISO, UMS, XHL	ENSG00000135111	T-box 3	O15119	12	114670254-114684164	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		seminal vesicle: 117.7	Cell type enriched	Detected in many	6	Syncytiotrophoblasts: 513.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4	Low region specificity	Detected in single			Not detected	Not detected			HPA005799, HPA075876			Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA005799: AB_1857817, HPA075876: 	unprognostic (3.27e-1)	unprognostic (2.64e-1)	unprognostic (2.84e-1)	unprognostic (1.11e-1)	unprognostic (3.40e-2)	unprognostic (5.97e-3)	unprognostic (1.56e-1)	unprognostic (2.99e-2)	unprognostic (9.43e-2)	unprognostic (1.15e-1)	unprognostic (3.35e-1)	unprognostic (3.06e-1)	unprognostic (3.64e-3)	unprognostic (1.09e-3)	unprognostic (1.43e-1)	unprognostic (1.01e-1)	prognostic favorable (3.28e-4)	4.3	60.5	0.9	3.3	1.9	0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0	0	0	0.3	0	0	0	0.7	6	0	0	9	12.4	13.5	34	32.4	13.2	13.1	5.3	1.4	0	0.5	5.9	0.8	1.5	2.8	1.2	16.3	0	4.1	0	1.5	15.5	2.9	0	0	5.5	0.8	4.4	9.1	0	0.1	0	1.2	0	1.1	0.5	0	0.1	0	17.2	1.8	0	0	0.8	0	42.4	2.2	6.6	4.8	2.2	1.1	15.8	1.7	0	0	4	2.6	2.3	11	0	0	0	8.5	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2	0	3.4	0.9	88	8.8	6.3	9.8	0	0	0	33.2	3.9	39.8	0	0.4	1.3	26.5	25.4	0	0	5.9	9.5	74	0	31	5.4	1.6	4.7	0.6	1.6	1.8	4.9	0.8	3.3	0	13.8	1.5	0.5	23	5.6	0	2	38.8	34.1	0.1	4.7	8.5	513.4	0.7	4.5	62.6	Syncytiotrophoblasts
CGA	FSHA, GPHa, GPHA1, HCG, LHA, TSHA	ENSG00000135346	Glycoprotein hormones, alpha polypeptide	P01215	6	87085498-87095406	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	62	pituitary gland: 398.8;placenta: 489.3	Cell type enriched	Detected in some	30	Syncytiotrophoblasts: 71349.9	Cancer enhanced	Detected in many		testis cancer: 13.0	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	28	BEWO: 73.5;SuSa: 141.5	Not detected	Not detected			Region enriched	Detected in single	11	hypothalamus: 69.2	CAB023350, HPA029698	Enhanced				Secreted to blood							CAB023350: AB_617281, HPA029698: AB_2673153	unprognostic (1.66e-1)	unprognostic (2.10e-1)		unprognostic (3.22e-5)	unprognostic (1.46e-2)	unprognostic (1.51e-1)	unprognostic (2.69e-2)	unprognostic (3.17e-1)			unprognostic (7.04e-3)	unprognostic (1.51e-1)		unprognostic (2.85e-1)	unprognostic (4.32e-2)	unprognostic (8.32e-2)	unprognostic (9.15e-3)	0.1	0.1	0	0.1	0	0.3	0	0	0	0	0	0	1.1	0	0.1	3.1	0	0	0	0.1	0	0	0.2	0.1	0.1	0	0	0	0	0.1	0	398.8	489.3	0.2	0.1	0	0	0.1	0.1	0.2	0.2	0	0.6	0	0.1	7.1	0	0	0	0.1	0	0	0.1	0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0	0.1	0	0	0	0	73.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	2.1	0	141.5	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	2.3	1.1	1	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.1	0	0	0	7	0	1223.9	0	0	0.1	0	0	0	0	2346.5	0.1	1.5	0	0	567.6	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	71349.9	0	0	0.3	Syncytiotrophoblasts
CYP19A1	ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM	ENSG00000137869	Cytochrome P450 family 19 subfamily A member 1	P11511	15	51208057-51338610	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase	Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	49	placenta: 440.1	Cell type enriched	Detected in some	36	Syncytiotrophoblasts: 1678.9	Low cancer specificity	Detected in single			Region enriched	Detected in single	8	basal ganglia: 5.9	Cell type enriched	Detected in single	17	neutrophil: 1.7	Lineage enriched	Detected in single	17	granulocytes: 1.7	Cell line enhanced	Detected in some		ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB000355, HPA051194	Enhanced		Uncertain	Mitochondria						Mitochondria		CAB000355: , HPA051194: AB_2681381	unprognostic (9.41e-2)	unprognostic (7.44e-2)	unprognostic (9.52e-5)	unprognostic (6.81e-2)	unprognostic (2.72e-1)	unprognostic (4.25e-4)	unprognostic (5.18e-5)	unprognostic (1.54e-3)	unprognostic (2.38e-2)	unprognostic (2.52e-1)	unprognostic (1.97e-1)	unprognostic (5.37e-2)	unprognostic (1.54e-5)	unprognostic (2.52e-3)	unprognostic (2.11e-1)	unprognostic (1.40e-2)	unprognostic (1.11e-1)	9	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3	0.2	0.3	3	0.2	0.2	1.2	0.5	0	0	1.7	0	0	0	0	0	0	0	0	0.8	45.7	2.8	0	0.1	0	0	0.1	0	0	0.1	0.2	0.1	0	0	0	0	7.9	0	0.3	0.1	3.7	0.3	0	0	15.3	0	0.1	1.9	0.1	0	0	0	0.3	0.1	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	1.1	0	8.1	0	0.2	0	0.1	0	0.1	0	1.4	0.6	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0	0	0	0	0	0	2	0	0	0	0	0	46.8	0	0	2.2	0	0	0	0	6.9	1.4	0	0	0	13.4	0	0	0	1.6	4.5	0.6	0	0	0	0	0	0.1	0	0.4	0	0	6.5	0.3	7.7	0.2	0	1678.9	0	0	0	Syncytiotrophoblasts
NECTIN4	LNIR, nectin-4, PRR4, PVRL4	ENSG00000143217	Nectin cell adhesion molecule 4	Q96NY8	1	161070995-161089599	Disease related genes, Predicted membrane proteins, Predicted secreted proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Receptor	Disease mutation, Ectodermal dysplasia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 40.1;placenta: 46.6;skin 1: 39.3	Cell type enriched	Detected in some	7	Syncytiotrophoblasts: 321.3	Low cancer specificity	Detected in many			Not detected	Not detected			Group enriched	Detected in some	7	basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6	Lineage enriched	Detected in single	12	granulocytes: 3.6	Cell line enhanced	Detected in some		BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3	Low region specificity	Detected in all			Not detected	Not detected			HPA010775	Enhanced		Supported	Plasma membrane	Secreted in other tissues	No	No		11000	Plasma membrane		HPA010775: AB_1079720	unprognostic (1.09e-3)	unprognostic (1.52e-1)	unprognostic (3.51e-1)	unprognostic (1.11e-2)	unprognostic (5.69e-3)	unprognostic (2.09e-2)	unprognostic (6.69e-3)	unprognostic (1.02e-1)	unprognostic (1.69e-1)	unprognostic (1.18e-1)	unprognostic (6.49e-3)	unprognostic (1.13e-1)	unprognostic (2.24e-8)	unprognostic (2.98e-2)	unprognostic (2.43e-1)	unprognostic (3.68e-2)	unprognostic (4.97e-2)	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0	0.1	0	0.5	4.4	0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2	0.1	0.1	4.5	0.2	0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0	5.2	0.1	0	0	0	0	28.2	0	0	0	0.1	0	7.1	0	0.1	0	0	18.2	0	0.6	0.1	0	0.2	0	0.4	5.3	0	0	0.3	0	7.2	1.5	1.8	0	0	0	0	0	0	11.4	0	0	0	11.8	0	0	0	0	0	8.5	0	0.1	0.1	23.7	0	3.3	15.3	0	0	0	1.2	0.2	0.1	0.1	0	0	0	0	0.1	1.5	0.1	1.2	0.2	0	0.1	0.2	0.2	0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	6	8.1	0	0	0	0	0	0	18.7	14.8	15.7	0	24.1	0	34.7	0	0	0	0	26.2	43.5	0	0	0	0	5.7	0	0	0	0	0	0	0.6	0	1.8	0	0	47.9	0	0	0	0	0	0	0	0	0	321.3	0	0	0	Syncytiotrophoblasts
CRH	CRF, CRH1	ENSG00000147571	Corticotropin releasing hormone	P06850	8	66176382-66178725	Plasma proteins, Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	placenta: 209.9	Cell type enriched	Detected in some	6	Syncytiotrophoblasts: 134.3	Cancer enriched	Detected in some	28	urothelial cancer: 34.5	Region enhanced	Detected in many		hypothalamus: 28.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	SCLC-21H: 1.4;SuSa: 5.0	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to blood			10000									unprognostic (1.62e-1)						unprognostic (9.68e-2)				unprognostic (1.00e-1)	unprognostic (9.55e-2)	unprognostic (7.22e-3)	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0	6.7	0.2	0.2	0.4	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0	0	0.5	0	0.2	0.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	1.4	0	0	0.1	0	5	0.2	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	2.1	0	6.7	2.7	28.4	0.4	1.1	13.8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0	20.7	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	11.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	134.3	0	0	0.1	Syncytiotrophoblasts
SLC26A2	DTD, DTDST	ENSG00000155850	Solute carrier family 26 member 2	P50443	5	149960737-149993455	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Transport		Disease mutation, Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		intestine: 81.9	Cell type enriched	Detected in many	4	Syncytiotrophoblasts: 676.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041957, HPA058090	Enhanced		Approved	Vesicles						Vesicles		HPA041957: AB_10795646, HPA058090: AB_2683602	unprognostic (6.64e-2)	unprognostic (1.53e-1)	unprognostic (3.03e-2)	prognostic favorable (7.29e-4)	unprognostic (2.59e-2)	unprognostic (5.64e-2)	prognostic unfavorable (4.66e-4)	unprognostic (2.59e-1)	unprognostic (5.64e-2)	unprognostic (1.19e-1)	unprognostic (7.43e-2)	unprognostic (2.10e-1)	prognostic unfavorable (3.27e-4)	unprognostic (1.70e-1)	unprognostic (1.77e-1)	unprognostic (8.12e-2)	unprognostic (1.06e-1)	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75	4.9	27.9	36.7	11.2	6	13.4	4.3	5.5	3	2.4	2.8	3	5.2	2.7	4.4	13	4.1	2.8	1.6	1.7	7	3.3	2.5	3	1.1	3.3	3	3.8	6.2	4.6	3.3	0.9	3.1	2.8	2.5	3.1	15.7	1.8	2.5	24.2	3.3	6.1	2.4	3.6	7.3	4.6	2	2.3	3.2	2.4	1.8	3.5	5.9	5.5	3.6	4.3	4.2	5.5	6.3	6	3.2	0.8	2.6	10.6	1	2.2	3.1	1.2	1.1	4.8	3.3	5.9	1.3	55.5	14.7	1.1	2.9	5.5	1.3	9.4	3.1	2.6	3.5	28.5	5.9	4.4	5.1	3.7	1.8	2.4	1.5	5.4	7.2	8.4	7	1.1	0.8	2.5	0.8	3	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3	41.7	13.7	7.5	12.5	4	16.1	6.7	7.6	6.7	14.8	31.4	15.7	160.9	1.7	5.2	17.7	15.3	151.8	0	8.6	5.2	16	21.5	87.8	2.4	26.4	6.4	20.3	16.5	13.8	9.9	16.1	12.2	86	16.2	37.7	15	9.4	147.9	11.7	4.4	80.3	0	10.2	9.2	10.2	4.4	676.5	9.6	53.2	4.9	Syncytiotrophoblasts
ATXN7	ADCAII, OPCA3, SCA7	ENSG00000163635	Ataxin 7	O15265	3	63898399-64003453	Disease related genes, Plasma proteins, Predicted intracellular proteins	Transcription, Transcription regulation		Disease mutation, Neurodegeneration, Spinocerebellar ataxia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 55.4	Cell type enriched	Detected in some	4	Syncytiotrophoblasts: 51.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 11.1	Low lineage specificity	Detected in many			Low cell line specificity	Detected in all											HPA034989			Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA034989: AB_10602596	unprognostic (1.51e-2)	unprognostic (2.44e-1)	unprognostic (5.98e-2)	unprognostic (2.18e-1)	unprognostic (1.92e-1)	prognostic favorable (1.22e-4)	unprognostic (9.65e-2)	unprognostic (2.76e-2)	unprognostic (2.46e-1)	unprognostic (2.12e-1)	unprognostic (7.82e-2)	unprognostic (9.77e-3)	unprognostic (2.56e-1)	unprognostic (8.04e-2)	unprognostic (1.74e-1)	unprognostic (9.19e-2)	unprognostic (3.45e-2)	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8	10.9	9.2	9.2	7.5	11.4	7.5	5	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	6	4.9	5	4.1	5.8	6.6	6.6	3.5	6.5	7.5	6.1	6.9	5.9	5.8	2.1	6.8	8.1	4	6.4	6.6	8	15.2	2.6	10.1	5.8	2.1	2.9	4.2	12.2	6.3	3.6	11.1	12.4	5.6	5.6	9.6	3.8	17.7	4.6	14.4	8.9	3.5	3.4	4.1	2.2	3.8	4.6	7	3.7	7.2	2	3.7	7.8	5.2	7.1	4.2	3.6	6.1	7.7	6.5	8.9	9.5	8.1	8	8.1	6.4	7.7	7.1	6.2	11.1	0.3	0.9	3.2	0.5	2.6	0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5	4.3	6.1	3.1	6	6.7	0	0	0	0	0	0	9	0	0	0	0	0	10.8	0	0	0	0	0	0	0	11.7	0	0	0	0	12.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	51.1	0	0	0	Syncytiotrophoblasts
CALHM4	C6orf78, FAM26D, FLJ32239	ENSG00000164451	Calcium homeostasis modulator family member 4	Q5JW98	6	116529013-116558868	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	placenta: 29.7;skin 1: 9.1	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 45.7	Not detected	Not detected			Region enriched	Detected in single	5	pons and medulla: 1.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	CACO-2: 2.8;SuSa: 6.2														Intracellular and membrane																	unprognostic (7.95e-2)			unprognostic (3.44e-4)		unprognostic (1.99e-1)	unprognostic (1.44e-2)		0.5	0	0	0	0.2	0	0.1	0	0.1	0	0.1	0.2	0.6	0	0	0.2	0.1	0	0	0.3	0.2	0.2	0.3	0	0	0	0.1	0	0	0	0.2	0	29.7	1.4	0	0	0.2	0	0	0.5	9.1	0	0	0	0	0	0.4	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	1	0.5	0.3	0.1	0	2.8	0	0.3	0.2	0.2	0.3	0	0.3	0.6	0.9	0	0	0	0	0.6	0	0	0	0.2	0	0	0	0.4	1	0	0	0	0.8	0	0	0	0.6	0	0	0	0	0	0	0	0	0.2	0	0.1	0	6.2	0.3	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0	0.1	0.2	0.2	0.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	10.1	0	0	0	0	0	0	0	0.3	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	45.7	0	0	0	Syncytiotrophoblasts
IL22RA2	CRF2-S1, IL-22BP	ENSG00000164485	Interleukin 22 receptor subunit alpha 2	Q969J5	6	137143820-137173648	Predicted secreted proteins		Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5	Cell type enriched	Detected in single	6	Syncytiotrophoblasts: 1.5	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	15	HL-60: 2.8;U-937: 5.0	Not detected	Not detected			Not detected	Not detected			HPA030582, CAB034906	Uncertain				Secreted to blood			40500000				CAB034906: AB_2124501, HPA030582: AB_10600716	unprognostic (1.09e-1)	unprognostic (7.97e-4)	unprognostic (1.32e-3)	unprognostic (1.24e-2)		unprognostic (4.03e-3)		unprognostic (1.11e-1)	unprognostic (4.51e-1)	unprognostic (1.92e-1)	unprognostic (1.07e-1)	unprognostic (1.10e-1)		unprognostic (7.58e-2)	unprognostic (1.32e-1)	unprognostic (1.62e-1)	unprognostic (6.61e-2)	0.1	0	0.1	2.5	0.1	0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0	0.2	0.3	0.1	0	0.1	0.1	0.1	2	0.1	0.1	0.1	0.1	0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.5	0	0	0	Syncytiotrophoblasts
DACT2	bA503C24.7, C6orf116, DAPPER2	ENSG00000164488	Dishevelled binding antagonist of beta catenin 2	Q5SW24	6	168292830-168319754	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	6	brain: 14.2;placenta: 54.8	Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 180.9	Cancer enhanced	Detected in many		endometrial cancer: 14.1	Region enriched	Detected in many	8	basal ganglia: 14.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5	Low region specificity	Detected in many							HPA030251	Enhanced	Supported										HPA030251: AB_10611108	unprognostic (5.22e-6)	unprognostic (3.13e-2)	unprognostic (1.04e-2)	prognostic favorable (1.07e-5)	unprognostic (1.21e-1)	unprognostic (1.41e-1)	unprognostic (1.64e-2)	unprognostic (1.08e-1)	unprognostic (4.04e-1)	unprognostic (1.31e-1)	unprognostic (7.05e-3)	unprognostic (2.48e-1)	prognostic favorable (5.76e-5)	unprognostic (1.51e-2)	unprognostic (1.66e-2)	unprognostic (2.03e-4)	unprognostic (4.23e-2)	1	1.3	0.5	0.4	14.2	0	0.4	1.5	1.4	2.3	1.1	1.2	1	0.9	3.7	2.2	0.7	2.2	2.9	2.7	0.9	0.5	2.2	2.4	2	0.4	1.1	0.9	0.9	1.6	0	0.4	54.8	1.7	6.1	0.4	1.6	5.3	0.5	0.4	5.6	0.8	0.8	0.7	0.4	0.5	1	0.7	0.9	0.4	0.4	0.8	1	0.4	0	0	0	0	0	0	0	0	4.5	0.1	0	0	0	0.1	0	0	0	0	3.6	0	0	2	0	0.1	0	0	0	0	0	0	0	0	2	0.6	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0.1	3.2	15.1	0	0	0	0	0	0	3.5	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	14.2	1.5	1.4	0.9	0.5	1.1	0.9	1.7	0.7	0	1.3	0	1.8	2.7	9.8	0.5	2.5	0	2.3	1.8	0	38.3	0	1.5	0	0.1	0	0	0.2	4.7	1.1	0.8	0	0	4.6	0	5.1	0	0	0	0	0	3.3	0	1.1	22.6	0.4	0	0	4.9	0.7	0	0	0	0	1.3	180.9	0	1.8	0	Syncytiotrophoblasts
SLC13A4	SUT-1, SUT1	ENSG00000164707	Solute carrier family 13 member 4	Q9UKG4	7	135681237-135729258	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	9	brain: 85.4;placenta: 44.8;retina: 23.5	Cell type enriched	Detected in some	7	Syncytiotrophoblasts: 657.3	Low cancer specificity	Detected in single			Region enriched	Detected in many	7	pons and medulla: 85.4	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HDLM-2: 25.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA048582	Enhanced											HPA048582: AB_2680450	unprognostic (2.40e-1)	unprognostic (2.51e-1)	unprognostic (9.70e-3)	unprognostic (1.78e-1)	unprognostic (7.69e-2)	unprognostic (3.96e-6)	unprognostic (3.33e-2)	unprognostic (1.32e-1)	unprognostic (8.56e-3)	unprognostic (9.23e-2)	unprognostic (2.89e-1)	unprognostic (1.87e-1)	unprognostic (2.30e-6)	unprognostic (1.53e-1)	unprognostic (3.07e-2)	unprognostic (2.00e-1)	unprognostic (6.73e-2)	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4	8.9	1.2	0.3	34	0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0	0.3	0	1.9	0.3	1.8	0	0.2	0.1	0.1	0	0.4	0	0	0	0	0	0	0.3	4.5	0.2	0.2	0	0	0	0	0	0.7	0.2	0	0	0	0	0	25.7	1.8	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0	2.8	0	0	0	0.1	0	2.1	0.1	0.1	2.1	0	0	0	0	0	0.1	0.1	0.1	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0.7	1.4	4	8.9	12.3	0.8	1.4	5.4	85.4	0.5	0	0	0	0.5	0	2.6	1.6	0	6.7	0	0	3.9	99.4	0	0.1	0.4	0.3	0	0	0	5.3	1.1	0.4	0	0	13.1	3.2	0	0	0	0	0.3	0	0	0	0	1	0.2	0	0	0	13.2	0	0	0	0.2	0.1	657.3	0	0	0.3	Syncytiotrophoblasts
KISS1		ENSG00000170498	KiSS-1 metastasis suppressor	Q15726	1	204190341-204196486	Cancer-related genes, Disease related genes, Predicted secreted proteins			Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	placenta: 267.2	Cell type enriched	Detected in many	41	Syncytiotrophoblasts: 1117.8	Cancer enhanced	Detected in many		urothelial cancer: 9.2	Group enriched	Detected in some	8	basal ganglia: 11.3;hypothalamus: 4.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	22	BJ: 55.9;U-2 OS: 22.8					Low region specificity	Detected in all			CAB017775, HPA035542	Enhanced		Approved	Vesicles	Secreted in female reproductive system					Vesicles		CAB017775: , HPA035542: AB_2674677	unprognostic (9.64e-2)	unprognostic (1.78e-2)	unprognostic (1.86e-2)	unprognostic (1.18e-2)	unprognostic (3.89e-1)	unprognostic (6.87e-2)	unprognostic (1.87e-1)	unprognostic (3.28e-2)		unprognostic (1.28e-2)	unprognostic (4.51e-2)	unprognostic (1.63e-1)	unprognostic (8.98e-12)	unprognostic (2.25e-1)	unprognostic (2.91e-2)	unprognostic (1.76e-1)	prognostic favorable (6.29e-6)	0.2	0	0.2	0.2	11.3	0	0.2	1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0.9	55.9	0.7	1	0.2	0	0.3	0	0.5	0	0	0	0	0	1.7	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0.3	0.1	0	0	0	0	0	0.3	0	0	0	0.2	0	0.3	0.1	0.1	0	0	22.8	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	11.3	1	0.2	0.2	4.2	0.2	0.2	0.2	0.2	0	0	0	4	0	0.5	0	0	0	0	0	0	6.3	0	3.3	27	0.3	5.1	0	4	4.1	0.4	1.8	0	2.9	14.5	0	0	1.3	0	3.1	0.3	0	0	0	0.6	0	2.9	0.8	0	1.2	0	0	0.1	0.1	0.4	0	1117.8	0	1.9	2.2	Syncytiotrophoblasts
PSG6		ENSG00000170848	Pregnancy specific beta-1-glycoprotein 6	Q00889	19	42902079-42919563	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	124	placenta: 330.8	Cell type enriched	Detected in some	204	Syncytiotrophoblasts: 304.0	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	27	neutrophil: 2.6	Lineage enriched	Detected in single	27	granulocytes: 2.6	Cell line enriched	Detected in some	17	U-2197: 57.9									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624						unprognostic (4.23e-1)												0.1	0.1	0.2	0	0.1	0.8	0.1	0.4	0.1	0.4	0	0	0	0	0.1	0	0.1	0.2	0	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	330.8	0	0	0	0	0.1	0	0	0.1	0	0.1	0.1	0	0	1.3	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0.1	0	0	0	0	0	0	0	3.4	0.2	0.2	0.4	0	0.1	0	0	0.7	0	0.1	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0.1	57.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0.3	1.5	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.6	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	304	0	0	0	Syncytiotrophoblasts
LEP	OB, OBS	ENSG00000174697	Leptin	P41159	7	128241284-128257628	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins			Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	adipose tissue: 85.2;breast: 63.7;placenta: 24.3	Cell type enriched	Detected in some	28	Syncytiotrophoblasts: 361.5	Cancer enhanced	Detected in some		breast cancer: 1.6	Not detected	Not detected			Cell type enriched	Detected in single	4	neutrophil: 3.8	Lineage enriched	Detected in single	7	granulocytes: 3.8	Group enriched	Detected in some	11	BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1	Not detected	Not detected			Not detected	Not detected			CAB010490	Approved				Secreted to blood			17000000	26000000			CAB010490: AB_2296951	unprognostic (8.19e-3)	unprognostic (5.33e-1)	unprognostic (1.60e-4)	unprognostic (1.19e-1)	unprognostic (7.99e-3)	unprognostic (1.83e-1)		unprognostic (6.56e-3)	unprognostic (1.98e-2)	unprognostic (1.42e-2)	unprognostic (2.45e-2)	unprognostic (2.63e-1)	unprognostic (1.02e-3)	unprognostic (2.83e-1)	unprognostic (1.92e-1)	unprognostic (2.23e-2)	unprognostic (6.84e-2)	85.2	0.3	0	1.5	0	0	63.7	0	0	0	0.6	0	0	0	0	0.4	0	0	0.5	0.7	0	0	0.1	0	0.4	2	0	0	0.1	0.7	0	0	24.3	0	0	0.1	0	0.4	0	0.6	1.1	0.4	0.2	0	0	0.2	0.1	0	0	0	0.1	0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0	0.2	0.1	0.3	0.2	0	5.6	0.1	0	0	0	0	0.2	0.3	0.1	0	0	0.2	0	0	0	0.1	0	0.2	0.1	0	0	0	0.2	2.3	0	0	0	0.1	0	0	0	0.3	0	0.3	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.3	0.1	0.2	0.1	0.3	0.1	7.1	0.2	0.1	0	0.2	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.1	0.3	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.9	0.2	0	0	0	0	0	0.4	0	0	0	0	0	0	0	13	0.2	0.1	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.1	361.5	0	0	0.1	Syncytiotrophoblasts
CRYBG2	AIM1L, FLJ38020	ENSG00000176092	Crystallin beta-gamma domain containing 2	Q8N1P7	1	26321698-26360080	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 43.9;placenta: 55.0	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 40.6	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3	Not detected	Not detected			Not detected	Not detected			HPA029629			Approved	Nucleoplasm						Nucleoplasm		HPA029629: AB_10601331	unprognostic (2.20e-1)	unprognostic (2.07e-2)	unprognostic (2.08e-1)	prognostic unfavorable (5.11e-6)	unprognostic (1.45e-1)	unprognostic (1.02e-1)	unprognostic (6.39e-4)	unprognostic (1.88e-3)	unprognostic (1.83e-1)	unprognostic (1.43e-1)	prognostic unfavorable (3.53e-4)	unprognostic (2.94e-2)	unprognostic (4.83e-9)	unprognostic (9.12e-3)	unprognostic (3.40e-1)	unprognostic (6.44e-2)	unprognostic (1.63e-2)	0	0	0	0.4	0	0	0.2	0	0	8	4.4	0	0	4.9	0.9	0.6	43.9	0.2	2	0	0	0	0.2	0	0.7	0	0	0	0.1	0	0	0	55	0	0.8	1.4	0.1	5.1	0	0	13.8	10.4	0	0	0	0.9	1.2	0	0.1	0	22	19.8	4.9	16.1	0.7	0	2.4	0.1	0.2	1.7	0.3	7.1	0	0	0	0	0	15.5	0	0	0	0.1	25.1	16.9	0.1	5.1	0	0.1	6.3	0	4.5	0	0	0.1	0	0	1	0	0	0	0	5.7	0.1	0	0	0	0.1	0	0	0	0.9	0	0	1.2	4	0	0	0	0.1	0.3	1.6	0.3	0	0	3	0	1.2	4.5	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0	0.1	0.5	1	0.1	0.5	0.7	1.7	0.7	0	0.6	0.5	0.5	2.4	0.2	0.1	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	4.9	1.7	1.8	0	0	0	0	1.2	4.3	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	7.7	0	0	1.2	0	0	0	0	0	0	40.6	0	0	0	Syncytiotrophoblasts
NECTIN3	CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3	ENSG00000177707	Nectin cell adhesion molecule 3	Q9NQS3	3	111070071-111275563	CD markers, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 94.2	Cell type enriched	Detected in some	4	Syncytiotrophoblasts: 98.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		memory CD4 T-cell: 1.7	Lineage enriched	Detected in single	4	T-cells: 1.7	Cell line enhanced	Detected in many		AF22: 33.5;TIME: 47.5	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB009869, HPA011038	Approved		Approved	Cell Junctions,Cytosol					20000000	Cytosol	Cell Junctions	CAB009869: AB_2284699, HPA011038: AB_1079719	unprognostic (3.76e-2)	unprognostic (3.81e-3)	unprognostic (1.74e-1)	unprognostic (1.97e-2)	unprognostic (1.02e-1)	unprognostic (9.77e-2)	unprognostic (3.26e-3)	unprognostic (3.77e-1)	unprognostic (7.58e-2)	unprognostic (3.94e-2)	unprognostic (5.33e-2)	unprognostic (7.04e-2)	prognostic favorable (9.82e-7)	unprognostic (2.01e-1)	unprognostic (1.97e-1)	unprognostic (2.67e-1)	unprognostic (1.05e-1)	5.6	4	5.4	4.4	6	0	4.5	1.3	8.9	4.6	12.6	6.5	2.8	17.8	5	2.2	3.5	5.4	4.4	4.8	6.3	5	6.9	16.4	5.6	1.9	6	4.1	9.2	4.7	1.9	1.9	94.2	5.5	6.9	12.6	10.7	3.4	4.8	2.3	1.8	18.9	7.2	8.9	1.8	13.2	27.6	4.5	0.4	24.1	2	1.4	5.4	7.7	0.1	0	0.3	0	0.2	1.7	0.7	0	10.1	33.5	2.2	13.6	25.2	2	22	23.3	13.7	11.7	9.3	4.7	0	7.3	31.3	7.6	0.1	9.3	3.2	25.2	0.2	2.5	0	3.6	0.7	23	1.6	0.3	12.7	1.4	9	8.7	12.3	11.5	0.4	0	8.8	29.5	0	2.2	0	9.4	3.1	3.6	0	16.6	0	8.5	5.3	0.8	6.1	0.4	0	4.6	11.7	0.3	0.1	47.5	17.4	7.2	3.1	13.1	4.9	0	0	11	0	16	0	0	0.3	0.1	0	1.2	0	1.7	1	0	0.1	0.3	0.4	0	0.2	0	0	0.1	0.7	5.4	6	1.3	8.9	6.3	5	6	4.1	5.5	4.5	23.8	7.3	0	0	0	0	0	0	1.4	5.7	12.2	0	3.3	0	3.9	0	0	0	0	16.4	7.6	0	0	1.1	0	0.8	0	0	0	0	0	0	0	0	1.8	0	0	13.3	0	0	6.6	0	0	0	0	0	0	98.1	0	0	0	Syncytiotrophoblasts
GREM2	CKTSF1B2, DAND3, FLJ21195, Prdc	ENSG00000180875	Gremlin 2, DAN family BMP antagonist	Q9H772	1	240489573-240612149	Disease related genes, Predicted secreted proteins		Cytokine, Developmental protein, Heparin-binding	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 90.3;parathyroid gland: 31.4	Cell type enriched	Detected in many	14	Syncytiotrophoblasts: 249.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		MAIT T-cell: 2.2;memory CD4 T-cell: 2.5	Lineage enriched	Detected in single	5	T-cells: 2.5	Cell line enriched	Detected in some	5	fHDF/TERT166: 26.5	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB009920	Approved				Secreted to blood							CAB009920: AB_2279266	unprognostic (2.01e-1)	unprognostic (2.49e-1)	unprognostic (7.41e-2)	unprognostic (7.58e-3)	unprognostic (2.82e-3)	unprognostic (1.34e-1)	unprognostic (8.18e-2)	unprognostic (1.90e-1)	unprognostic (1.31e-2)	unprognostic (6.40e-2)	unprognostic (2.78e-1)	unprognostic (1.97e-2)	unprognostic (3.07e-8)	unprognostic (1.22e-1)	unprognostic (2.36e-1)	unprognostic (5.13e-2)	unprognostic (1.38e-2)	0.6	0.9	3	9.5	4.5	0	2.2	0.7	5.1	0.8	14.2	0.5	0.9	6.5	8.2	1.9	10.7	1.3	90.3	0.2	2.1	3.6	1.1	21.9	1.3	0.6	1.4	4.8	4.2	0.3	31.4	5.2	5.2	3	2.8	12.8	1.7	7.5	1.1	6.5	2.3	11.7	3.8	1.8	1.7	6.4	0.5	0.9	0	0.7	3	4.1	2.2	0.7	0	0	0.5	0	0.1	2.5	0.2	0	0	0.1	0	1.6	2.1	0	5.1	5.4	0	0	0	0	0	0	26.5	0	0	1.4	0	0	0	0.2	0	0.4	0	0	0	0	0.4	0	0.1	0	0.2	0	0	0	1	0.1	0	0	0	1.2	0	0	0	0	0	0	0	0	1.2	0	1.9	0	2.5	1.1	0	0	3.3	0.4	0.7	0.3	0.9	0	0	2.8	0	1.6	0	0	0	0	0	2.2	0	2.5	1.3	0	0	0.6	0	0.5	0.1	0	0	0	0.2	3	4.5	0.7	5.1	2.1	3.6	1.4	4.8	3	0.9	0	0	0	0	4.1	17.3	0.3	0	1.4	0	0	11.8	4.3	0	0	0	0	0	0	0	1.1	1	0.3	0	10.5	1.5	0	1.2	0	0.3	0	0	0	1.7	0	0	0.8	0.1	0	4.2	0	6.1	0	2.2	0.4	0.4	3.1	249.2	0	0	0.1	Syncytiotrophoblasts
IGSF5	JAM4	ENSG00000183067	Immunoglobulin superfamily member 5	Q9NSI5	21	39745407-39802096	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		heart muscle: 5.8	Cell type enriched	Detected in some	9	Syncytiotrophoblasts: 95.4	Cancer enhanced	Detected in some		testis cancer: 2.3					Cell type enriched	Detected in single	5	neutrophil: 2.2	Lineage enriched	Detected in single	5	granulocytes: 2.2	Cell line enhanced	Detected in many		T-47d: 10.8					Low region specificity	Detected in all			HPA057282	Uncertain		Approved	Focal adhesion sites						Focal adhesion sites		HPA057282: AB_2683395	unprognostic (1.06e-1)	unprognostic (2.53e-1)	unprognostic (7.06e-2)	unprognostic (9.73e-5)	unprognostic (1.56e-2)	unprognostic (3.15e-1)		unprognostic (1.41e-1)	unprognostic (2.18e-2)	unprognostic (2.09e-1)	unprognostic (8.35e-2)	unprognostic (9.61e-2)	unprognostic (4.01e-1)	unprognostic (4.18e-1)	unprognostic (3.75e-2)	unprognostic (6.89e-2)	unprognostic (1.07e-2)	0	2	0.9	0	3.4	0.1	1.3	0.1	0.7	1.1	0.3			0.2	0.9	3.4	0	0.9	0.3	5.8	1.2	2.3	0.3	0.3	0.1	0.2	1.3		1.5	2.5	0.3	1.5	4.3		2.4	0.9		0.9	0.4	0	0.6	0.1	0.4	0.7	0.3	0.6	1.5			0.8		0.2	0.5	0.2	0.4	0.3	2.2	0.4	0	0.4	0	1.3	0.7	4.5	1.1	4.4	3.6	1.2	0.8	1.2	1.3	2	0.7	1.3	1.4	1.2	1.7	1.7	1.2	1.5	3	2.5	2.3	2.1	1.4	3.3	0.5	2.8	1.9	0.6	3.2	5.5	2.9	3.2	2.2	0.6	0.7	2.6	0.9	1.7	1.6	0.3	0.6	2.5	1.1	0.8	0.7	2	0.8	1.9	1.9	2	0.5	1.2	3	1.8	2.1	10.8	1.1	0.4	2	2.3	1	1.8	1	0.8	0.9	1.1	1.4	2	0.1	0.4	0.4	0.4	0	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.2	2.2	0	0.1	0.3	0	0											0	0	0	0.2	0	1.3	8.7	0	0	0	1.8	0	0.9	5	0.3	11.1	0	0	0	0.2	0.9	0	0.9	0	0	0.4	0	0	0	0	4.5	0.3	0	0	0	0	0.9	0.1	0	0.4	2.7	0.1	0	0.2	0.5	0.1	0	95.4	0	0	0.9	Syncytiotrophoblasts
PSG9	PSG11, PSGII	ENSG00000183668	Pregnancy specific beta-1-glycoprotein 9	Q00887	19	43211791-43269530	Plasma proteins, Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	205	placenta: 299.0	Cell type enriched	Detected in some	109	Syncytiotrophoblasts: 231.8	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 1.4	Lineage enriched	Detected in single	15	granulocytes: 1.4	Cell line enhanced	Detected in some		BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624	unprognostic (9.32e-2)	unprognostic (3.28e-1)				unprognostic (2.15e-1)												0.1	0	0.1	0	0.1	0	0.1	0.6	0.1	0.2	0.1	0	0	0	0.2	0	0.1	0	0	0	0.1	0.2	0.6	0	0	0	0.1	0	0	1.3	0	0.2	299	0	0.2	0	0	0.5	0.1	0	0.1	0	0.4	0.2	0.1	0.1	0.8	0	0	0	0	0	0.1	0.3	0	0	1.4	0	0	0	0	0.1	0	0	0	0	0	0.1	5	2.8	4.4	2.3	0.1	0.1	0	0.2	1.3	16	0.3	0	0	9.2	0	0	0	0	0	0.3	0	0	0	0	0	0.3	1.1	0	0	0	0	0	2.8	0	0	0	0	0	0	0.1	0	0.3	0.5	0	0	0	0	0.5	11	4.2	0	0.2	0.1	2.1	9.5	0.2	0	0	0	0.3	0	0	0.5	0	1.4	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.5	0.5	0	0	0	0	2.1	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	231.8	0	0	0	Syncytiotrophoblasts
ZNF703	FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1	ENSG00000183779	Zinc finger protein 703	Q9H7S9	8	37695751-37700021	Disease related genes, Predicted intracellular proteins	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 64.6	Cell type enriched	Detected in many	4	Syncytiotrophoblasts: 363.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	8	intermediate monocyte: 5.5;non-classical monocyte: 6.7	Lineage enriched	Detected in single	12	monocytes: 6.7	Cell line enhanced	Detected in many		HEK 293: 55.7;OE19: 21.1;SK-MEL-30: 20.1;T-47d: 18.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA023930, CAB068249	Supported											CAB068249: AB_2665667, HPA023930: AB_1859425	unprognostic (4.64e-2)	unprognostic (3.15e-2)	unprognostic (7.01e-3)	unprognostic (1.71e-3)	unprognostic (2.54e-1)	unprognostic (1.42e-1)	unprognostic (6.93e-2)	unprognostic (4.23e-2)	unprognostic (1.35e-1)	unprognostic (1.84e-1)	unprognostic (4.09e-1)	unprognostic (9.63e-2)	prognostic unfavorable (2.70e-7)	unprognostic (5.63e-2)	unprognostic (1.52e-1)	unprognostic (1.01e-1)	unprognostic (2.23e-1)	12.7	6.7	9.3	8.2	8.4	2.4	15.4	7.2	10.1	25.1	20	4.6	31.3	14	13.8	19.5	15.3	18.4	12.1	8	8.5	3.6	3.5	2.1	4.9	4	5.4	4.7	15	4.3	2	3.1	54.9	7.8	15.1	12.3	12	13.7	17.7	64.6	24.6	15.4	14.9	3.4	13.4	12.6	4.9	5.5	1.9	5.3	24	7.2	20.4	13.8	0	0.5	0.1	6.7	0	0.1	0.2	1.1	2.3	0.3	1.8	5.5	2.9	1.8	10.2	4.8	3.1	2.7	9.4	12.7	0	2.6	6.4	1.4	6	1	1.5	2.4	0.3	55.7	0	3.3	6	5.5	0	1.1	9.8	2.9	3.3	1.3	6.8	2.7	0.1	0.1	0	5	9.4	0	0.3	0.9	21.1	4.1	0.9	1.7	1.2	0.9	4.9	1	0.1	1.9	1.6	20.1	2.3	18.7	1	8.1	3.7	8.7	5.7	4.2	0.7	0	0	3.3	1.1	2.4	0	0.7	0.1	0	5.5	0	0	0	0	0.5	0	0	0.1	0	0	6.7	0	0	0.2	9.3	8.4	7.2	10.1	8.5	3.6	5.4	4.7	7.8	5.5	6	0	6.2	10.8	42.7	3.5	7.6	2.5	2.7	2.3	5.2	0	33	3.3	7.7	0.3	5	32.1	0	2.2	34.7	27.2	9.5	0	1.7	29.3	0	76.4	3.7	9.1	0	29.1	11.7	32.1	0	83.3	8.3	2.6	52.6	14.9	2.1	0.8	51.8	81.2	0	0.6	65.2	363.1	0.7	82.3	9.5	Syncytiotrophoblasts
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712326-41715969	Cancer-related genes, Predicted secreted proteins		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	61	stomach 1: 529.2	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 7.3	Group enriched	Detected in many	6	pancreatic cancer: 38.8;stomach cancer: 23.5	Region enhanced	Detected in single		cerebral cortex: 1.2	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	OE19: 27.5	Low region specificity	Detected in some			Not detected	Not detected			CAB000038	Enhanced				Secreted to digestive system				43000			CAB000038: 		unprognostic (1.27e-1)	unprognostic (4.27e-3)		unprognostic (1.12e-1)	unprognostic (1.07e-2)		unprognostic (2.75e-2)		unprognostic (5.68e-2)	unprognostic (2.11e-1)			unprognostic (2.85e-1)	unprognostic (3.17e-1)		unprognostic (9.07e-2)	0	0	0.1	0	0.4	0	0	0	1.2	0.1	1.7	6.9	0	2.4	7.3	0	0	0	2.6	0	0.1	0.3	0.2	0.1	0	0	0.1	0	0	0.1	0	0.1	5.1	0	0	0	0	0	0	0	0.1	0	0	0.1	0.3	529.2	0.1	0	8.6	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0.1	0	0	0	0.2	0	0	0.3	0	0	4.3	0	0.2	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	27.5	0	0.5	0	0.3	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	1.2	0.1	0.3	0.1	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0.4	0	0	1.3	0	0	0	0	0	0	0.1	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	7.3	0	0	0.1	Syncytiotrophoblasts
KRTAP19-5	KAP19.5	ENSG00000186977	Keratin associated protein 19-5	Q3LI72	21	30501657-30502117	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	27	skin 1: 23.5	Cell type enriched	Detected in single	18	Syncytiotrophoblasts: 1.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HEK 293: 10.3																		2100000																					0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.5	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	10.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	Syncytiotrophoblasts
CGB5	HCG	ENSG00000189052	Chorionic gonadotropin beta subunit 5	P0DN86	19	49043884-49045311	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	8	placenta: 105.2	Cell type enriched	Detected in some	7	Syncytiotrophoblasts: 16.5	Cancer enhanced	Detected in some		pancreatic cancer: 10.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	24	BEWO: 46.9;U-251 MG: 21.3									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted to blood					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277		unprognostic (1.38e-1)				unprognostic (1.68e-1)					unprognostic (1.51e-3)			prognostic unfavorable (1.18e-5)	unprognostic (1.07e-1)		prognostic unfavorable (9.47e-4)	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0.1	0	0	0	0	2.1	0.1	12.7	105.2	0	0.6	0	0	0.1	0	0.2	0.6	0	0	0	0	0.2	0.7	0	0	0	0	0	0	0.3	0	0	0	0	0	0.5	0	1.4	0.2	0	0	0	0	46.9	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	1.1	0	21.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	2.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	16.5	0	0	0	Syncytiotrophoblasts
CGB7	CG-beta-a	ENSG00000196337	Chorionic gonadotropin beta subunit 7	P0DN87	19	49054275-49058860	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		skin 1: 8.1	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 49.1	Not detected	Not detected			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted in other tissues					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277	unprognostic (9.53e-2)	unprognostic (1.99e-1)	unprognostic (1.87e-1)	unprognostic (3.53e-1)	unprognostic (4.60e-5)	unprognostic (2.64e-1)	unprognostic (2.46e-1)	unprognostic (8.37e-2)	unprognostic (2.88e-2)	unprognostic (4.80e-2)	unprognostic (8.83e-4)	unprognostic (1.54e-1)	unprognostic (3.89e-8)	unprognostic (1.63e-2)	unprognostic (1.94e-1)	unprognostic (2.05e-1)	unprognostic (9.28e-2)	0.3	0.2	0.3	0.3	0.3	0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4	1	2	2	0.4	0.2	1	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0	2.7	3.7	1.3	4.6	0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0	0	0	0	0.3	0	3.2	0.8	0.2	1.5	0	0.2	7.1	0.6	0	1.4	1.2	1.2	2.6	0	0.1	1.3	2.1	5.7	0.2	4.8	0.5	0.1	0.3	0	0	0	0.3	0	0.3	0.4	6.9	0.4	0.7	1.6	0	0	0	0.2	1.3	0.3	0	0	0	0	0	0.1	0.1	0	0	4	0.1	0.1	1.4	0.1	0.1	1.7	1	0.2	0.2	2.3	2.3	0	10.4	0.3	0.4	0	1.1	0.1	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0.3	0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3	0	0.3	0	0	0.6	0	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0	0	2.7	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	9.6	0	0	0	0	0	0	0.6	0.3	0	49.1	0	0	0	Syncytiotrophoblasts
CSHL1	CS-5, CSHP1, CSL, hCS-L, MGC149868	ENSG00000204414	Chorionic somatomammotropin hormone like 1	Q14406	17	63909597-63918838	Predicted intracellular proteins, Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	864	pituitary gland: 334.1;placenta: 293.7	Cell type enriched	Detected in some	16	Syncytiotrophoblasts: 18.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7									CAB025646, HPA043715	Enhanced				Secreted to blood							CAB025646: , HPA043715: AB_2678632																		0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	0.2	0	334.1	293.7	0	0.1	0	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	1.3	0.4	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	18.1	0	0	0	Syncytiotrophoblasts
DPRX		ENSG00000204595	Divergent-paired related homeobox	A6NFQ7	19	53632056-53637009	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		placenta: 4.9;skeletal muscle: 4.2	Cell type enriched	Detected in some	4	Syncytiotrophoblasts: 4.7	Cancer enriched	Detected in single	20	thyroid cancer: 2.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 2.5;SuSa: 3.3									HPA043682	Uncertain											HPA043682: AB_10963073												unprognostic (2.47e-1)			unprognostic (1.89e-1)			2	0	0.1	0	0.1	0	1.3	0.1	0	0.2	0.1			0	0.1	1.8	0	0.1	0	1.2	0.2	0	0	0.1	1.6	0	0.1		0	0	0	0	4.9		0.7	0		0	0.1	4.2	0.5	0	0.1	0.1	0.1	0	1.6			0		0	0	0	0	0	0.6	0.2	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0.6	0	0.1	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0.7	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0.2	0	4.7	0	0	0	Syncytiotrophoblasts
PSG5	FL-NCA-3, PSG	ENSG00000204941	Pregnancy specific beta-1-glycoprotein 5	Q15238	19	43166256-43186536	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	73	placenta: 171.3	Cell type enriched	Detected in some	41	Syncytiotrophoblasts: 605.9	Low cancer specificity	Detected in single			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	8	BJ: 52.4;fHDF/TERT166: 180.6									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624	unprognostic (1.59e-1)	unprognostic (3.38e-2)				unprognostic (4.69e-2)		unprognostic (1.62e-2)	unprognostic (2.18e-1)	unprognostic (2.04e-1)	unprognostic (1.75e-2)		unprognostic (1.12e-2)	unprognostic (2.62e-2)		unprognostic (1.03e-1)	unprognostic (7.92e-2)	0.3	0	0	0	0.1	0	0.2	0.9	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	2.3	0	0	0	0	0	0	1.1	0.2	0.1	171.3	0	0	0	0	0.9	0	0	1.2	0	0.4	0	0.1	0.1	0.1	0	0	0	0	0	0	0	1	0.5	2	0.5	0.6	0.7	0	0.1	0	0	0	0	0	0	52.4	15.1	0.8	7.3	0	0	0	0	180.6	0.2	2	0	0	8.3	0	0	0	0	0	0	0	0	0.1	0	0.1	0.9	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0.2	6.8	0	0	0	0	0	0	0	1.7	0.5	0.4	0.7	0.4	0.5	0.6	0.5	0.5	0.2	1	0.7	0.5	2	0.6	0.4	0.5	0.4	0	0	0.1	0.9	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0.4	0.1	0	0	0	1.8	0	5.3	0	4.3	0.8	0	0	0	0	14.9	0	0	0	0	2.3	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	0	0.1	0	0	0	0	0	605.9	0	0	0	Syncytiotrophoblasts
CGB8		ENSG00000213030	Chorionic gonadotropin beta subunit 8	P0DN86	19	49047638-49049106	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	85	pituitary gland: 7.0;placenta: 22.2	Cell type enriched	Detected in some	15	Syncytiotrophoblasts: 37.1	Cancer enhanced	Detected in some		testis cancer: 5.9					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	BEWO: 61.9;U-251 MG: 21.5									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted to blood					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277		unprognostic (3.35e-2)				unprognostic (1.72e-1)					unprognostic (7.44e-3)				unprognostic (4.70e-1)		unprognostic (1.67e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0.1	0	0	0	0	0	0	0	0	0	0		0	0	0.1	7	22.2		0	0		0	0	0	0.1	0	0	0	0	0	0.1			0		0	0	0	0	0	0	0	0	0	0	5.6	0.3	0	0	0	0	61.9	0	0	0.2	0	0	1.9	0	0	0.3	1.4	0.4	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	3.9	0	0.2	0	1.2	2.6	0.2	21.5	0	0.1	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	2.5	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	37.1	0	0	0	Syncytiotrophoblasts
CSH2	CS-2, CSB, hCS-B	ENSG00000213218	Chorionic somatomammotropin hormone 2	P0DML3	17	63872012-63873766	Predicted intracellular proteins, Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	36	placenta: 246.2	Cell type enriched	Detected in some	25	Syncytiotrophoblasts: 230.4	Cancer enhanced	Detected in single		testis cancer: 0.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	25	BEWO: 10.2;SuSa: 15.3									HPA043715	Supported				Secreted to blood							HPA043715: AB_2678632		unprognostic (1.68e-1)								unprognostic (1.85e-1)					unprognostic (1.86e-1)			0.3	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	6.7	246.2	0	0	0	0	0	0	0	0.1	0	1.1	0	0.4	0.3	0.6	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	10.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.1	0	0	0	15.3	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	7.4	0	0	0	0	9.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	230.4	0	0	0	Syncytiotrophoblasts
TCL1B	TML1	ENSG00000213231	T cell leukemia/lymphoma 1B	O95988	14	95686417-95692643	Predicted intracellular proteins			Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3	Cell type enriched	Detected in some	13	Syncytiotrophoblasts: 60.8	Cancer enriched	Detected in single	72	testis cancer: 8.3	Not detected	Not detected			Group enriched	Detected in some	23	naive B-cell: 13.0;plasmacytoid DC: 5.9	Group enriched	Detected in many	23	B-cells: 13.0;dendritic cells: 5.9	Cell line enriched	Detected in some	7	U-698: 104.8					Not detected	Not detected			HPA053163	Uncertain		Approved	Cytosol						Cytosol		HPA053163: AB_2682064															unprognostic (1.55e-1)			0.1	0.2	0.1	0.9	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0	0	0	0.4	1.4	0.4	0.1	0	0.1	0.1	0.1	1.1	0.1	0.1	5.3	0.1	0	0.2	0.1	0	0.1	12.7	0	0.3	0	0	0.1	0	0.1	0.1	0.6	0	0.1	1.8	0.1	7.3	0	0	0.1	0	5.4	0.1	0.1	13	5.9	0.3	0	0.4	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0.1	0	0.5	0.1	0	0	0	0.2	0	0	0	0.1	104.8	0	0	0	0	0	0	0	0	0	0	0	0	0	13	0	0	0.3	0.4	0	5.9	0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.1	0	0	0.2	0	0	0	0	2	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	4.7	0	60.8	0	0	0	Syncytiotrophoblasts
PSG3		ENSG00000221826	Pregnancy specific beta-1-glycoprotein 3	Q16557	19	42721638-42740569	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	146	placenta: 495.8	Cell type enriched	Detected in some	171	Syncytiotrophoblasts: 1321.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624																		0.1	0.1	0.1	0	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	495.8	0	0	0	0	0.1	0	0	0	0	0.2	0.1	0	0	3.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.8	0.7	0.4	0.1	0	0	0	0.5	0.6	0.6	0.1	0	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	3.5	0	0	0	0	0.1	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	3.5	6.3	0	0	0	0	7.7	0	0	0	0	3.6	0	0	0	0	1.4	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0.1	0	1321	0	0	0	Syncytiotrophoblasts
PSG7		ENSG00000221878	Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)		19	42924132-42937178	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in some	8	placenta: 23.1	Cell type enriched	Detected in some	105	Syncytiotrophoblasts: 135.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.9;U-2197: 4.8									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624																		0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0.3	0	23.1	0	0	0	0	0	0	0	2.8	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	4	0.9	0.2	1.3	0	0	0	0	2.8	0.9	0.1	0	0.1	5.9	0	0	0	0	0	0	0	0	0	0	1.2	1.3	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.9	0	0	0	0.1	0	4.8	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	1.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	135.5	0	0	0	Syncytiotrophoblasts
PSG1	CD66f, PBG1, PSBG1, PSGGA	ENSG00000231924	Pregnancy specific beta-1-glycoprotein 1	P11464	19	42866464-42879822	CD markers, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	362	placenta: 497.6	Cell type enriched	Detected in some	130	Syncytiotrophoblasts: 173.1	Cancer enhanced	Detected in single		thyroid cancer: 0.5	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.0	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	18	U-2197: 98.0									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624					unprognostic (2.02e-1)	unprognostic (3.54e-1)							unprognostic (2.44e-7)			unprognostic (2.28e-2)		1.3	0	0.1	0	0.1	0	0.6	0.5	0.2	0.3	0.1	0	0	0	0	0	0.1	0.1	0	0.2	0.1	0.1	0.2	0	0	0	0.1	0	0	0.2	0.1	0.1	497.6	0	0	0	0	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0	0	0.5	0	0	0.2	0	0.2	0	1	0.3	0	0.1	0	0	0.1	0	0	0	0	0	4.2	1.4	0.3	0.5	0	0	0	0	4.8	1	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0.5	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	5.4	0	0	0.1	0	0	98	0	0	0	0	0	0	0	0.4	0	0.1	0	0	0.1	0.1	0	0	0	0.2	0	0.1	1	0	0.3	0	0.1	0	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0	0.2	1.3	0	0	0	0	0	0	0.5	0	0.1	0.6	0	0	0	0	0.7	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	173.1	0	0	0	Syncytiotrophoblasts
H2BFS		ENSG00000234289	H2B histone family member S	P57053	21	43565189-43565648	Predicted intracellular proteins		Antibiotic, Antimicrobial, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	4	lymphoid tissue: 65.0	Cell type enriched	Detected in single	5	Syncytiotrophoblasts: 3.3	Not detected	Not detected							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8									HPA042205, HPA043013, HPA048671	Supported		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488					unprognostic (1.29e-1)					unprognostic (4.33e-3)				unprognostic (2.06e-2)				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4	3.3	12.2	0.1	0.5	2.2	4.2	0	0	4.5	0.4	5.3	1.8	0.8	3	2.1	1	0.4	3	1.8	0.7	5.7	2	7.9	0	65	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16	4.9	1.6	3.6	3.2	2.1	3.3	0.6	0.9	2.2	0.9	2.4	2.6	1.3	3.2	2	4.6	1.1	0.6	8.8	0.8	2.5	2.5	0.2	0.7	0.9	2.2	3.6	0.6	5	0.2	0.3	0.9	4.5	2.5	0.4	0.6	0	1.2	0.3	0.4	23.7	2.8	0.9	6.1	1	2.2	0.3	4.1	2.6	0.8	0.5	8.7	0.7	0.7	3.5	2.5	10.5	3.2	2.1	0.5	11.1	1.4	0.9	1.7	23.4	1.1	0.6	7.6	23.8	5	1.1	11.8	1	10	2.1	15	1.2	2.2	1	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16	1.6	4.9	6.2	3.6	3.2											0	0	0	0	0	0	0.3	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.7	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	Syncytiotrophoblasts
KIAA0040		ENSG00000235750	KIAA0040	Q15053	1	175156987-175192999	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 315.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA016895, HPA068812	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA016895: AB_2669476, HPA068812: AB_2686041	unprognostic (5.98e-2)	unprognostic (1.43e-1)	unprognostic (1.77e-1)	unprognostic (2.99e-2)	unprognostic (1.01e-2)	unprognostic (8.54e-3)	unprognostic (2.91e-1)	unprognostic (2.87e-2)	unprognostic (3.83e-1)	unprognostic (1.21e-1)	unprognostic (2.66e-2)	unprognostic (1.63e-1)	unprognostic (2.53e-2)	unprognostic (1.49e-1)	unprognostic (2.57e-1)	unprognostic (2.28e-2)	unprognostic (3.05e-1)	25.7	4	2.7	18.4	7.4	5.1	16	2	3.9	8	7.7	1.8	3.5	5.2	8.6	7.9	7	9.2	11	16.3	3.2	2.9	17.8	12.1	25.3	16.1	6.9	1	5	17.9	4.6	13.6	45.6	7.6	7.9	5.6	12.2	15.2	4.1	11.1	5.1	10.2	6	5.4	27.6	9.8	3.4	3.5	14.8	9.6	7.2	18.6	6.6	10.7	16.5	5.4	26.4	6.1	3.3	9.6	5.4	3.1	0.1	0.1	0	0	0	0	1.4	3.8	0	0	1.6	4.6	32.8	7.8	0	0.1	13.2	2.3	15.4	0	11.1	1.9	3.5	7.2	0.2	0.4	0.2	0.4	0	4.2	0	5.9	0	5.1	4.8	2.8	5.5	0	0.7	4.1	0	1	2.7	2.8	3.5	1.7	23.3	5	7.9	0.2	1.2	2.4	12.9	0.3	8.4	8.2	0.7	2	0	1.5	0	0.3	13.6	16.5	42.2	0.6	0	3.5	12.8	6.1	1	5.9	3.3	5.3	16.2	6.5	4.9	5.4	16.5	6.9	5.9	26.4	3.3	1.2	1.2	9.6	5.4	2.7	7.4	2	3.9	3.2	2.9	6.9	1	7.6	3.5	35.7	5.6	53.8	61.7	23.7	0	3.1	12.7	20.1	15.9	12.2	0	57.4	11.6	11.3	0.5	20.2	11.2	0	20.8	5.6	39.4	46.5	10.5	6	10.4	0	4.1	13.5	10.6	1.2	15.5	16.9	6.8	10	5.5	4.3	17.8	14.2	9.9	4.7	0	25.8	65.9	0.3	3.3	9.7	315.3	25.4	10.3	30.7	Syncytiotrophoblasts
PSG2	CEA, PSBG2, PSG1, PSGGB	ENSG00000242221	Pregnancy specific beta-1-glycoprotein 2	P11465	19	43064211-43083045	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	102	placenta: 75.3	Cell type enriched	Detected in some	35	Syncytiotrophoblasts: 671.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 6.5;fHDF/TERT166: 14.0;HBF TERT88: 21.8;SuSa: 6.1;U-2197: 28.0														Secreted in female reproductive system																					unprognostic (1.02e-2)				0.4	0	0.2	0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0	0.1	0	0	0.2	0	0	75.3	0	0.1	0	0	0.2	0	0.1	0.7	0	0.2	0	0.1	0.1	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	6.5	1.1	0.6	2.9	0	0	0	0	14	0.8	0.3	0	0	21.8	0	0	0	0	0	0	0	0	0	0	0.6	0.8	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	6.1	0	0	0	0	0	28	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0.3	0.3	0.4	0	0	0	0	0	0	3.6	0	0.8	0.2	0	0	0	0	19.2	0.3	0.5	0	0	1.6	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	671	0	0	0.6	Syncytiotrophoblasts
PSG11	MGC22484, PSG13, PSG14	ENSG00000243130	Pregnancy specific beta-1-glycoprotein 11	Q9UQ72	19	43007656-43026512	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	220	placenta: 151.1	Cell type enriched	Detected in single	172	Syncytiotrophoblasts: 135.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	U-2197: 19.7									HPA042240, HPA046327	Enhanced				Secreted in female reproductive system							HPA042240: AB_10797384, HPA046327: AB_2679624					unprognostic (2.58e-1)													0.2	0	0	0	0.1	0	0.1	0.2	0.1	0.2	0.1	0	0	0	0.1	0	0.1	0	0	0.1	0.1	0.2	0.1	0.1	0	0	0	0	0	0.1	0	0.1	151.1	0	0	0	0	0	0	0.1	0.1	0	0.4	0.1	0.1	0.1	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.5	0.2	0	0.1	0	0	0	0	0.7	0.3	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0.4	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	19.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.8	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	135.4	0	0	0	Syncytiotrophoblasts
PSG4		ENSG00000243137	Pregnancy specific beta-1-glycoprotein 4	Q00888	19	43192702-43207299	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	placenta: 348.5	Cell type enriched	Detected in some	54	Syncytiotrophoblasts: 463.1	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	fHDF/TERT166: 107.6;U-2197: 29.2									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624	unprognostic (4.29e-2)	unprognostic (5.18e-2)		unprognostic (9.49e-2)		unprognostic (2.52e-2)		unprognostic (3.63e-2)	unprognostic (1.94e-1)	unprognostic (2.07e-2)	unprognostic (1.70e-1)	unprognostic (7.75e-2)	unprognostic (8.82e-3)	unprognostic (1.03e-3)	unprognostic (1.68e-2)	unprognostic (2.85e-1)	unprognostic (2.57e-1)	0.6	0.4	0.2	0.5	0.2	0	1.4	0.2	0.2	0.2	8.2	0.2	0.2	0	0.2	0.2	1.2	0	0.2	0.2	0.2	0	2	0.2	0.2	0.2	0.2	0.2	0.2	2	49.1	0.6	348.5	0.2	0.6	5.8	0.2	4.4	0.2	0.2	6.3	0.2	0.2	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1	0	0	0.6	0.4	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0.1	0	0	0.5	0	0.3	107.6	0.8	0.1	0	0	1	0	0	0	0	0	0	0	0	0.1	0	1.6	11	0.7	0	0	0	0	0.8	0	0	0	0	0.3	0	0	0	0	0.4	0	0	0	0	1.4	0.1	3	0	0	0.8	0.4	1.1	29.2	0	0	0	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	3	0	0.7	0.3	0	0	0	0	0	1.3	0	4.9	0	0	0	0	0	8.5	0.2	0.2	0	0	1.9	0	0	0	0	0	0	0	0	1	0	0	1.1	0	0	0	0	0	0	0	0.1	0	463.1	0	0	0.3	Syncytiotrophoblasts
ERVFRD-1	envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2	ENSG00000244476	Endogenous retrovirus group FRD member 1, envelope	P60508	6	11102489-11111732	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	placenta: 66.9	Cell type enriched	Detected in some	52	Syncytiotrophoblasts: 481.3	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 2.1	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	SuSa: 30.4																						unprognostic (1.99e-1)	unprognostic (3.29e-4)	unprognostic (4.75e-2)	unprognostic (1.80e-1)	unprognostic (1.34e-1)	unprognostic (2.19e-3)	unprognostic (3.35e-1)	unprognostic (6.44e-2)	unprognostic (1.24e-1)	unprognostic (1.99e-1)	unprognostic (1.30e-2)	unprognostic (2.78e-3)	unprognostic (5.80e-4)	unprognostic (3.40e-2)	unprognostic (1.82e-1)	unprognostic (1.95e-2)	unprognostic (1.37e-2)	1.4	2	0.1	0.1	0.1	0.1	0.8	0.2	0.2	0.5	0.8	0.1	0.1	0.3	1.3	0.8	0.7	0.2	0.5	0.5	0.1	0	1.5	0.7	1.5	1	0.1	0.1	0.1	0.1	15.8	0.1	66.9	0.1	1.2	0.2	0.7	0.9	0.5	0.1	0.9	1.9	0.8	0.1	0.1	1	0.3	0.1	0.6	0.2	0.9	0.3	1.5	2.2	0.5	0	0.3	0.1	2.1	0.7	0.1	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	30.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0.5	0.7	0.4	0.3	2.1	0	0	0	0.1	0.1	0.1	0.2	0.2	0.1	0	0.1	0.1	0.1	0.1	0	2.6	0	0	0	0.9	0.4	0	0	1.2	0	0	3.7	0	0	0	0	0	0	0	1.6	0	0	9.3	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	481.3	0	0	0	Syncytiotrophoblasts
LGALS16		ENSG00000249861	Galectin 16	A8MUM7	19	39655894-39660647	Predicted intracellular proteins	Apoptosis			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	placenta: 14.2	Cell type enriched	Detected in some	76	Syncytiotrophoblasts: 852.8	Cancer enriched	Detected in single	11	testis cancer: 0.5	Region enhanced	Detected in some		cerebellum: 2.6	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	105	BEWO: 5.5;SuSa: 16.1																																							0	0	0.1	0	0.1	0	0	2.6	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	1.3	0	0	0	0	1.2	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	16.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0.1	2.6	0.5	0.1	1.3	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.4	0	0	0.7	0	0	0	0	4.4	0	0	0	0	11.2	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	852.8	0	0	0	Syncytiotrophoblasts
DPEP2NB		ENSG00000263201	DPEP2 neighbor		16	68013436-68015911	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 3.6;placenta: 2.8;testis: 5.7	Cell type enriched	Detected in some	46	Syncytiotrophoblasts: 54.9	Not detected	Not detected							Group enriched	Detected in some	29	eosinophil: 3.6;neutrophil: 2.1	Lineage enriched	Detected in single	37	granulocytes: 3.6	Cell line enhanced	Detected in some		JURKAT: 1.7;SuSa: 1.4;U-2197: 1.5	Not detected	Not detected																									unprognostic (1.91e-1)											unprognostic (3.22e-2)	0	0		0		1.2	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		2.8		0	0		0	0	0	0	0	0		0	0	5.7			0		0	0		0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.5	0	0	0	0.1	0	0	0.5	0	0	0	0	0.3	0	0	0	0.2	0	0	0.8	0	0	0	1.7	0.1	0	0	0	0	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0	0	1.4	0	0.3	0	0	0	1.5	0.1	0	0	0.1	0.3	0.4	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54.9	0	0	0	Syncytiotrophoblasts
ZNF488	FLJ32104	ENSG00000265763	Zinc finger protein 488	Q96MN9	10	47365496-47384273	Predicted intracellular proteins	Neurogenesis, Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	7	brain: 29.7;intestine: 25.8	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 30.2	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA035957, HPA035958			Supported	Nucleoplasm,Cytosol	Intracellular and membrane					Nucleoplasm, Cytosol		HPA035957: AB_10672234, HPA035958: AB_2674887	unprognostic (3.29e-2)	unprognostic (1.05e-2)	unprognostic (7.87e-2)	unprognostic (1.49e-4)	unprognostic (1.16e-1)	unprognostic (8.85e-2)	unprognostic (1.60e-3)	unprognostic (2.13e-2)	unprognostic (3.11e-1)	unprognostic (2.45e-1)	prognostic unfavorable (4.02e-7)	unprognostic (3.60e-1)	unprognostic (6.62e-5)	unprognostic (2.76e-1)	unprognostic (4.47e-1)	unprognostic (8.10e-2)	unprognostic (3.18e-2)	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17	0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6	0.7	0.3	0.3	0	4.1	21.4	0.6	1.1	0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0	0.3	0	0.9	0.7	0	0	0	0	0.2	0	0	0	2.4	6.8	1.2	0.3	0	0	0.1	0.2	0.3	0.4	0.4	2.7	6.4	0.1	0.4	0	2.7	23.7	0.6	2.6	0.3	34.3	0.7	0.1	0.7	0.2	0	0	0.3	0	6.2	0.2	0.6	0.1	0	1.3	0	0	0	0.1	0.2	0.1	1.8	5.1	0.6	0	3	0	0.1	19.1	5.7	1	1.6	0.2	0	2.7	0.5	0	0	0	1.8	0	0.3	0	0	0	0	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.8	0.6	0.8	0.3	0	0	0	0	0	5.6	5	0.3	0	0	1	0	0.2	0.3	0.2	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	1.4	0.1	0.3	0	0	0	0	0	0.1	0	1.3	0.1	30.2	0	0.8	0.3	Syncytiotrophoblasts
CGB1		ENSG00000267631	Chorionic gonadotropin beta subunit 1	A6NKQ9	19	49035610-49036895	Predicted intracellular proteins, Predicted secreted proteins		Hormone		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	pancreas: 8.4	Cell type enriched	Detected in single	125	Syncytiotrophoblasts: 58.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	HMC-1: 20.5									HPA038925, HPA038934	Uncertain		Approved	Cytosol	Secreted to blood					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277																		0	0.1	0	0	0	0	0	0	0	0	0			0.6	0	0	0	0	0	0	0	0	0	0	0	0	0		0	8.4	0	1.4	0.1		0	0		0	0	0	0.1	0.1	0	0	0	0.1	1.8			0		0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	1.4	0	0	0.1	0	0.6	0.3	0	0	0	0	0	0.2	0	0	0.1	0.6	0	0.2	0	0	0	20.5	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0.2	0.3	0.1	0	0	0	0	0.1	0.3	0.2	0.1	0.9	0	0.1	0.1	0	0	0.5	0.3	4.1	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	58.5	0	0	0	Syncytiotrophoblasts
ERVV-2	ENVV2	ENSG00000268964	Endogenous retrovirus group V member 2, envelope	B6SEH9	19	53044738-53051076	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	105	placenta: 85.9	Cell type enriched	Detected in single	5	Syncytiotrophoblasts: 3.2	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BEWO: 19.1;SuSa: 12.9;T-47d: 5.4									HPA076115			Approved	Centrosome,Cytosol						Cytosol	Centrosome	HPA076115: 				unprognostic (3.14e-3)		unprognostic (2.06e-1)				unprognostic (1.31e-1)			unprognostic (4.33e-9)	unprognostic (3.01e-2)	unprognostic (1.68e-1)	unprognostic (1.05e-1)	unprognostic (2.60e-4)	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.7	0	0	0	0.8	0	0	0	0	0	85.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.7	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	19.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	12.9	5.4	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	Syncytiotrophoblasts
ERVV-1	ENVV1, FLJ32214, HERV-V1	ENSG00000269526	Endogenous retrovirus group V member 1, envelope	B6SEH8	19	53013921-53016122	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	placenta: 19.7	Cell type enriched	Detected in some	31	Syncytiotrophoblasts: 218.2	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	BEWO: 11.7;SuSa: 9.8									HPA076115			Approved	Centrosome,Cytosol						Cytosol	Centrosome	HPA076115: 	unprognostic (1.04e-3)			unprognostic (7.32e-3)	unprognostic (2.97e-1)	unprognostic (2.70e-2)		unprognostic (1.67e-2)		unprognostic (9.92e-2)		unprognostic (6.75e-2)	unprognostic (4.34e-5)	unprognostic (3.48e-2)	unprognostic (5.80e-2)	unprognostic (3.18e-1)	unprognostic (1.35e-1)	0	0	0	0	0	0	0	4.1	0	0.9	0			0	0	0	0	0	0	0.2	0	0	0.2	0	0	0	0		0	0	0	0	19.7		0.8	0		0	0	0.2	0	0	0	0	0	0	0			0		0	1.3	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	11.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	9.8	0.1	0	0	0	0	0	0	0.2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	7.1	0	0	0	0	0	0	0	1.5	0	0.1	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	218.2	0	0	0	Syncytiotrophoblasts
